Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 42,183Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Mavyret

PharmaCompass

01

Brand Name : Mavyret

arrow
Antibody Engineering
Not Confirmed

Glecaprevir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,830

2019 Revenue in Millions : 2,893

Growth (%) : -37

Abbvie Company Banner

02

Brand Name : Mavyret

arrow
Antibody Engineering
Not Confirmed

Glecaprevir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 1,710

2020 Revenue in Millions : 1,830

Growth (%) : -7

Abbvie Company Banner

03

Brand Name : Mavyret

arrow
Antibody Engineering
Not Confirmed

Glecaprevir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 1,541

2021 Revenue in Millions : 1,710

Growth (%) : -10

Abbvie Company Banner

04

Brand Name : Mavyret

arrow
Antibody Engineering
Not Confirmed

Glecaprevir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 1,430

2022 Revenue in Millions : 1,541

Growth (%) : -7

Abbvie Company Banner

05

Brand Name : Mavyret

arrow
Antibody Engineering
Not Confirmed

Glecaprevir/Pibrentasvir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2018 Revenue in Millions : 3,438

2017 Revenue in Millions : 0

Growth (%) : New Launch

Abbvie Company Banner

06

Brand Name : Mavyret

arrow
Antibody Engineering
Not Confirmed

Glecaprevir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 2,893

2018 Revenue in Millions : 3,438

Growth (%) : -16

Abbvie Company Banner